Wellbutrin and Hyperacusis - a phase IV clinical study of FDA data

Summary:

Hyperacusis is reported as a side effect among people who take Wellbutrin (bupropion hydrochloride), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Lithium Carbonate, and have Epilepsy.

The phase IV clinical study analyzes which people have Hyperacusis when taking Wellbutrin. It is created by eHealthMe based on reports of 101,581 people who have side effects when taking Wellbutrin from the FDA, and is updated regularly.

What is Wellbutrin?

Wellbutrin has active ingredients of bupropion hydrochloride. It is often used in depression. eHealthMe is studying from 117,110 Wellbutrin users. Check the latest studies of Wellbutrin.

What is Hyperacusis?

Hyperacusis (disorder in loudness perception) is found to be associated with 402 drugs and 608 conditions by eHealthMe. Check the latest studies of Hyperacusis.

On Aug, 02, 2026

101,581 people reported to have side effects when taking Wellbutrin.
Among them, 61 people (0.06%) have Hyperacusis.

Among these 61 people:

How long have people been on Wellbutrin when they have Hyperacusis? *

What is the gender of people who have Hyperacusis when taking Wellbutrin? *

female: 79.66 %
male: 20.34 %

What is the age of people who have Hyperacusis when taking Wellbutrin? *

What are other drugs people take besides Wellbutrin? *

What are other side effects people have besides Hyperacusis? *

Blindness Transient (sudden loss of vision): 20 people, 32.79%
Deafness Transitory (deafness temporary): 19 people, 31.15%
Rashes (redness): 18 people, 29.51%
Feeling Abnormal: 16 people, 26.23%
Nausea (feeling of having an urge to vomit): 14 people, 22.95%
Loss Of Consciousness: 13 people, 21.31%
Memory Loss: 12 people, 19.67%
Swelling Face: 10 people, 16.39%
Itching: 9 people, 14.75%
Insomnia (sleeplessness): 9 people, 14.75%

What are the existing conditions these people have? *

Migraine (headache): 19 people, 31.15%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 19 people, 31.15%
Indigestion: 16 people, 26.23%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 15 people, 24.59%
Fungal Infection: 14 people, 22.95%
Blood Testosterone Abnormal: 13 people, 21.31%
Fungal Nail Infection: 11 people, 18.03%
Seasonal Affective Disorder (a type of depression that occurs at a certain time of the year, usually in the winter): 11 people, 18.03%
Affective Disorder (mental disorder): 10 people, 16.39%
Asthma: 8 people, 13.11%

* Approximation only. Some reports may have incomplete information.

Do you take Wellbutrin and have Hyperacusis?

- Check whether Hyperacusis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Wellbutrin:

Wellbutrin (117,110 reports)

Hyperacusis treatments and more:

Hyperacusis (4,388 reports)

Browse all side effects of Wellbutrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperacusis:

Hyperacusis (402 drugs)

Browse all the conditions that are associated with Hyperacusis:

Hyperacusis (608 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bupropion hydrochloride (the active ingredients of Wellbutrin) and Wellbutrin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.